ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) /

The debt of ADAPTIVE BIOTECHNOLOGIES CORPORATION over the past 9 years

Chart ADAPTIVE BIOTECHNOLOGIES CORPORATION: liquid cash, total debt, net cash, fiscal 2017–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, ADAPTIVE BIOTECHNOLOGIES CORPORATION had liquid cash of $226.98M and total debt of $131.21M: net cash of $95.77M. It had more liquid cash than debt at all 9 year-ends shown. Total debt was highest at the end of fiscal 2024 ($133.28M) and lowest at the end of fiscal 2017 ($0).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$226.98M*$131.21M$95.77M
2024ended Dec 31, 2024$222.29M*$133.28M$89.02M
2023ended Dec 31, 2023$346.4M*$130.66M$215.74M
2022ended Dec 31, 2022$498.2M*$125.36M$372.84M
2021ended Dec 31, 2021$353.06M*$0$353.06M
2020ended Dec 31, 2020$688.27M*$0$688.27M
2019ended Dec 31, 2019$576.87M*$0$576.87M
2018ended Dec 31, 2018$165.02M*$0$165.02M
2017ended Dec 31, 2017$192.15M*$0$192.15M

Fiscal years as ADAPTIVE BIOTECHNOLOGIES CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ADAPTIVE BIOTECHNOLOGIES CORPORATION

Companies of a similar size

Not investment advice. This page shows what ADAPTIVE BIOTECHNOLOGIES CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.